Widening for clopidogrel BE study [Outliers]

posted by mittyri – Russia, 2021-06-16 18:04 (1217 d 12:22 ago) – Posting: # 22419
Views: 5,675

Dear Loky do

❝ is widening of Cmax accepted in clopidogrel BE studies with fully replicate design or not?


You linked the EMA Q&A where it is stated unequivocally:
Under these circumstances, the widening of 90% confidence intervals for Cmax is not recommended.

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,258 posts in 4,886 threads, 1,661 registered users;
69 visitors (0 registered, 69 guests [including 14 identified bots]).
Forum time: 06:27 CEST (Europe/Vienna)

I’m not a pessimist,
I’m just a well informed optimist.    José Saramago

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5